Imaging endogenous dopamine competition with [11C]raclopride in the human brain
The DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.
Abstract
This study images dopamine release in response to a neurochemically specific challenge with the psychostimulant drug methylphenidate. Changes in synaptic dopamine induced by methylphenidate were evaluated with positron emission tomography and [11 C]raclopride, a D 2 receptor radioligand that is sensitive to endogenous dopamine. Methylphenidate significantly decreased striatal [11 C]raclopride binding. The decrease was variable and was negatively correlated with age. Mood and anxiety at baseline, were also correlated with methylphenidate‐induced DA changes. This strategy provides a tool to investigate the responsiveness of the dopamine system in the normal and diseased human brain and to investigate the neurochemical correlates of behavior. © 1994 Wiley‐Liss, Inc.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Di Chiara, G., & Imperato, A. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.14.5274 · Cited by 4,733
Neurogenetic Adaptive Mechanisms in Alcoholism
Cloninger, C. R. (1987) · Science · doi:10.1126/science.2882604 · Cited by 2,234
Dopamine Receptor Binding Predicts Clinical and Pharmacological Potencies of Antischizophrenic Drugs
Creese, I., Burt, D. R., & Snyder, S. H. (1976) · Science · doi:10.1126/science.3854 · Cited by 2,220
Cocaine Receptors on Dopamine Transporters Are Related to Self-Administration of Cocaine
Ritz, M. C., Lamb, R. J., Goldberg, S. R., & Kuhar, M. J. (1987) · Science · doi:10.1126/science.2820058 · Cited by 2,180
Cellular and molecular mechanisms of drug dependence
Koob, G. F., & Bloom, F. E. (1988) · Science · doi:10.1126/science.2903550 · Cited by 2,070 · cited 1×
“Dopamine (DA) is a neurotransmitter that plays a major role in movement, motivation, and reward (Koob and Bloom, 1988; Le Moal and Simon, 1991; Ritz et al., 1987; Wise, 1988).”
BackgroundAntipsychotic drug doses and neuroleptic/dopamine receptors
SEEMAN, P., LEE, T., CHAU-WONG, M., & WONG, K. (1976) · Nature · doi:10.1038/261717a0 · Cited by 1,622
Aromatic Amino Acids and Modification of Parkinsonism
Cotzias, G. C., Van Woert, M. H., & Schiffer, L. M. (1967) · New England Journal of Medicine · doi:10.1056/nejm196702162760703 · Cited by 1,494
Logan, J., Fowler, J. S., Volkow, N. D., Wolf, A. P., Dewey, S. L., Schlyer, D. J., MacGregor, R. R., Hitzemann, R., Bendriem, B., Gatley, S. J., et al. (1990) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1990.127 · Cited by 1,479
Self-citationDOPAMINE (3-HYDROXYTYRAMINE) AND BRAIN FUNCTION
HORNYKIEWICZ, O. (1966) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)07154-6 · Cited by 1,442
Factors That Predict Individual Vulnerability to Amphetamine Self-Administration
Piazza, P. V., Deminière, J.-M., Le Moal, M., & Simon, H. (1989) · Science · doi:10.1126/science.2781295 · Cited by 1,351
Research works printed but not linked: 9
- Davis K. L., 1991, Dopamine in schizophrenia: a review and reconceptualization. Am. J, Psychiatry, 148, 1474
- Ekman G., 1967, The measurement of subjective reactions, Forsvarsedicine, 33, 27
- Ferris R., 1972, A comparison of the capabilities of isomers of amphetamine, deoxyperadrol and methylphenidate to inhibit the uptake of catecholamines into rat cerebral cortex slices, synaptosomal preparations of rat cerebral cortex, hypothalamus and striatum and into adrenergic nerves of rabbit aorta, J. Pharmacol., 14, 47
- Innis R. B., 1993, SPECT imaging demonstrates loss of striatal dopamine transporters in parkinson's disease, J. Nucl. Med., 34, 31
- Joseph J. A., 1990, The striatum, a microcosm for the examination of age‐related alterations in the CNS: a selected review. Rev. Biolog. Res, Aging, 4, 181
- Kandel D. B., 1989, Cessation of illicit drug use in young adulthood. Arch. Gen, Psychiatry, 46, 109
- Logan J., 1993, The effects of changes in blood flow on the distribution volume of [11C]raclopride binding, J. Nucl. Med., 34, 200
- Raichle M. E., 1983, Brain blood flow measured with intravenous H2 15O, J. Nucl. Med., 24, 790
- Wong D. F., 1992, C‐11 WIN 35,428 imaging of the dopamine transporter site in living human brain, J. Nucl. Med., 33, 964
Cited by
Items 101–200 of 379
Yau, Y. H. C., Crowley, M. J., Mayes, L. C., & Potenza, M. N. (2012) · PubMed · Cited by 150
Seeman, P., Tallerico, T., & Ko, F. (2003) · Synapse · doi:10.1002/syn.10232 · Cited by 128
Conditioned and sensitized responses to stimulant drugs in humans
Leyton, M. (2007) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2007.08.027 · Cited by 127
Smith, G. S., Reynolds, C. F., Pollock, B., Derbyshire, S., Nofzinger, E., Dew, M. A., Houck, P. R., Milko, D., Meltzer, C. C., & Kupfer, D. J. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.5.683 · Cited by 125
PET measures of amphetamine-induced dopamine release in ventral versus dorsal striatum
Drevets, W. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(99)00079-2 · Cited by 122
“…cocaine) and during performance of neuropsychological tasks presumed to increase DA release (Breier et al. 1997; Carson et al. 1997; Dewey et al. 1993; Hartvig et al. 1997; Koepp et al. 1998; Laruelle et al. 1996, 1997; Price et al. 1998; Schlaepfer et al. 1997; Volkow et al. 1994).”
BackgroundA new PET ligand for the dopamine transporter: studies in the human brain.
Volkow, N. D., Ding, Y., Fowler, J. S., Wang, G., Logan, J., Gatley, S. J., Schlyer, D. J., & Pappas, N. R. (1995) · PubMed · Cited by 120
Self-citationEmerging Association Between Addictive Gaming and Attention-Deficit/Hyperactivity Disorder
Weinstein, A. M., & Weizman, A. (2012) · Current Psychiatry Reports · doi:10.1007/s11920-012-0311-x · Cited by 128
“This is comparable to amounts of dopamine released by amphetamine [52] or methylphenidate [53, 54].”
ResultStriatal and extrastriatal dopamine release measured with PET and [18F] fallypride
Slifstein, M., Kegeles, L. S., Xu, X., Thompson, J. L., Urban, N., Castrillon, J., Hackett, E., Bae, S. ‐., Laruelle, M., & Abi‐Dargham, A. (2010) · Synapse · doi:10.1002/syn.20734 · Cited by 115
“Similar studies have been performed with other dopaminergic stimulants such as methylphenidate (Volkow et al., 1994).”
ResultTomasi, D., Wang, G.-J., Wang, R., Caparelli, E. C., Logan, J., & Volkow, N. D. (2015) · Human Brain Mapping · doi:10.1002/hbm.22617 · Cited by 111
Self-citationPET studies of binding competition between endogenous dopamine and the D1 radiotracer [11C]NNC 756
Abi-Dargham, A., Simpson, N., Kegeles, L., Parsey, R., Hwang, D.-R., Anjilvel, S., Zea-Ponce, Y., Lombardo, I., Van Heertum, R., Mann, J. J., et al. (1999) · Synapse · doi:10.1002/(sici)1098-2396(199905)32:2<93::aid-syn3>3.0.co;2-c · Cited by 115
Seneca, N., Finnema, S. J., Farde, L., Gulyás, B., Wikström, H. V., Halldin, C., & Innis, R. B. (2006) · Synapse · doi:10.1002/syn.20238 · Cited by 110
“see Laruelle, 2000; Laruelle et al., 1995; Volkow et al., 1994 ).”
BackgroundVolkow, N. D., Wang, G., Fowler, J. S., Molina, P. E., Logan, J., Gatley, S. J., Gifford, A. J., Ding, Y., Wong, C., Pappas, N. R., et al. (2003) · Psychopharmacology · doi:10.1007/s00213-002-1340-7 · Cited by 119
Self-citationVolkow, N. D., Wiers, C. E., Kojori, E. S., Tomasi, D. G., Wang, G., & Baler, R. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.01.012 · Cited by 117
“This strategy, which was first applied in humans to investigate the effects of intravenous (IV) methylphenidate (MP)(Volkow et al. 1994) and subsequently to investigate the effects of amphetamine (Laruelle et al. 1996), showed that both stimulant drugs significantly increased DA in the brain.”
Self-citationImpulsivity and chronic stress are associated with amphetamine-induced striatal dopamine release
Oswald, L. M., Wong, D. F., Zhou, Y., Kumar, A., Brasic, J., Alexander, M., Ye, W., Kuwabara, H., Hilton, J., & Wand, G. S. (2007) · NeuroImage · doi:10.1016/j.neuroimage.2007.01.055 · Cited by 108
Effects of Serotonin Transporter Promoter Polymorphisms on Serotonin Function
Smith, G. S., Lotrich, F. E., Malhotra, A. K., Lee, A. T., Ma, Y., Kramer, E., Gregersen, P. K., Eidelberg, D., & Pollock, B. G. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300552 · Cited by 115
“Such a paradigm has been developed for the dopamine system using the dopamine (D2) receptor radiotracer, [11C]raclopride and acute pharmacologic interventions of the dopamine system (eg Dewey et al, 1993; Volkow et al, 1994).”
MethodWilleit, M., Ginovart, N., Graff, A., Rusjan, P., Vitcu, I., Houle, S., Seeman, P., Wilson, A. A., & Kapur, S. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301400 · Cited by 107
“…behavioral (Koepp et al, 1998; de la FuenteFernandez et al, 2002; Pruessner et al, 2004; Zald et al, 2004; Volkow et al, 2006) and pharmacological manipulations (Farde et al, 1992; Volkow et al, 1994; Tedroff et al, 1996; de la Fuente-Fernandez et al, 2004), which raise endogenous dopamine levels.”
BackgroundGABAergic attenuation of cocaine-induced dopamine release and locomotor activity
Dewey, S. L., Chaurasia, C. S., Chen, C.-E., Volkow, N. D., Clarkson, F. A., Porter, S. P., Straughter-Moore, R. M., Alexoff, D. L., Tedeschi, D., Russo, N. B., et al. (1997) · Synapse · doi:10.1002/(sici)1098-2396(199704)25:4<393::aid-syn11>3.0.co;2-w · Cited by 119
Memory and frontal lobe functions; possible relations with dopamine D2 receptors in the hippocampus
Takahashi, H., Kato, M., Hayashi, M., Okubo, Y., Takano, A., Ito, H., & Suhara, T. (2007) · NeuroImage · doi:10.1016/j.neuroimage.2006.11.008 · Cited by 101
Catecholamines and cognition after traumatic brain injury
Jenkins, P. O., Mehta, M. A., & Sharp, D. J. (2016) · Brain · doi:10.1093/brain/aww128 · Cited by 107
“The dopaminergic ligands available can be used to assess synthesis capacity, receptor density as well as dynamic endogenous release of dopamine (Farde et al., 1987; Volkow et al., 1994; Cumming et al., 1997).”
BackgroundSimonyan, K., Berman, B. D., Herscovitch, P., & Hallett, M. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.0407-13.2013 · Cited by 103
PET-based molecular imaging in neuroscience
Jacobs, A. H., Li, H., Winkeler, A., Hilker, R., Knoess, C., R�ger, A., Galldiks, N., Schaller, B. J., Sobesky, J., Kracht, L. W., et al. (2003) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-003-1202-5 · Cited by 106
Sun, W., Ginovart, N., Ko, F., Seeman, P., & Kapur, S. (2003) · Molecular Pharmacology · doi:10.1124/mol.63.2.456 · Cited by 99
Smoking produces rapid rise of [11C]nicotine in human brain
Berridge, M. S., Apana, S. M., Nagano, K. K., Berridge, C. E., Leisure, G. P., & Boswell, M. V. (2010) · Psychopharmacology · doi:10.1007/s00213-010-1809-8 · Cited by 104
“Imaging studies have related this to the rate of rise of both methylphenidate (Spencer et al. 2006) and cocaine in the brain (Gatley et al. 1995, 1997; Volkow et al. 1990, 1994, 1995, 1996a, b, 1997, 1999).”
BackgroundThe advantage of using positron emission tomography in drug research
Farde, L. (1996) · Trends in Neurosciences · doi:10.1016/0166-2236(96)40002-9 · Cited by 94
Hume, S. P., Opacka‐Juffry, J., Myers, R., Ahier, R. G., Ashworth, S., Brooks, D. J., & Lammertsma, A. A. (1995) · Synapse · doi:10.1002/syn.890210107 · Cited by 93
The role of dopamine in alcohol self-administration in humans: individual differences
Barrett, S. P., Pihl, R. O., Benkelfat, C., Brunelle, C., Young, S. N., & Leyton, M. (2008) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2008.01.008 · Cited by 92
“Although drug-induced increases in DA release have been reported to correlate with both euphoric (Laruelle et al., 1995; Volkow et al., 1994; Drevets et al., 2001; Martinez et al., 2003; Abi-Dargham et al., 2003; Barrett et al., 2004; Oswald et al., 2005) and craving responses to abused substances…”
BackgroundA literature review of dopamine in binge eating
Yu, Y. H., Miller, R. M., & Groth, S. W. (2022) · Journal of Eating Disorders · doi:10.1186/s40337-022-00531-y · Cited by 101
“The radiotracer [11C]raclopride has a high selectivity and affinity to the D2 receptor; thus, it competes with endogenous dopamine binding to the D2 receptor—when endogenous dopamine increases, the radioligand signal decreases [46].”
BackgroundDevelopment of ligands for in vivo imaging of cerebral nicotinic receptors
Sihver, W., Nordberg, A. K., Långström, B., Mukhin, A. G., Koren, A. O., Kimes, A. S., & London, E. D. (2000) · Behavioural Brain Research · doi:10.1016/s0166-4328(00)00209-6 · Cited by 90
Montgomery, A. J., Asselin, M.-C., Farde, L., & Grasby, P. M. (2007) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600339 · Cited by 85
“MP is a dopamine transporter (DAT) blocker which has been shown to increase extracellular concentrations of dopamine in striatal regions in humans (Volkow et al, 1994) and in extrastriatal brain regions in rodents (Wayment et al, 2001).”
BackgroundHeterogeneous Effects of Alcohol on Dopamine Release in the Striatum: A PET Study
Yoder, K. K., Constantinescu, C. C., Kareken, D. A., Normandin, M. D., Cheng, T., O'Connor, S. J., & Morris, E. D. (2007) · Alcoholism: Clinical and Experimental Research · doi:10.1111/j.1530-0277.2007.00390.x · Cited by 83
“…such as amphetamine (Breier et al., 1997; Drevets et al., 2001; Leyton et al., 2002; Martinez et al., 2003, 2005; Munro et al., 2006a, 2006b; Oswald et al., 2005), methylphenidate (Volkow et al., 1994, 1997, 1999; Wang et al., 1999), and nicotine (Barrett et al., 2004; Brody et al., 2004, 2006).”
Biomarker Approaches in Major Depressive Disorder Evaluated in the Context of Current Hypotheses
Jentsch, M. C., Van Buel, E. M., Bosker, F. J., Gladkevich, A. V., Klein, H. C., Oude Voshaar, R. C., Ruhé, H. G., Eisel, U. L., & Schoevers, R. A. (2015) · Biomarkers in Medicine · doi:10.2217/bmm.14.114 · Cited by 80
Mukherjee, J., Yang, Z.-Y., Lew, R., Brown, T., Kronmal, S., Cooper, M. D., & Seiden, L. S. (1997) · Synapse · doi:10.1002/(sici)1098-2396(199709)27:1<1::aid-syn1>3.0.co;2-9 · Cited by 85
Narendran, R., & Martinez, D. (2008) · Synapse · doi:10.1002/syn.20566 · Cited by 83
“In addition to measuring DA receptor binding in the striatum, [11C]raclopride can be used to measure striatal DA transmission (Drevets et al., 2001; Martinez et al., 2003; Volkow et al., 1994).”
Dopaminergic Mechanisms Underlying Normal Variation in Trait Anxiety
Berry, A. S., White, R. L., Furman, D. J., Naskolnakorn, J. R., Shah, V. D., D’Esposito, M., & Jagust, W. J. (2019) · Journal of Neuroscience · doi:10.1523/jneurosci.2382-18.2019 · Cited by 86
“High doses of amphetamines and cocaine, which increase extracellular dopamine, are anxiogenic (Angrist and Gershon, 1970; Volkow et al., 1994; David et al., 2001), and alter activation in rACC and amygdala (Hariri et al., 2002; Moeller et al., 2014).”
BackgroundResultApplication of cross-species PET imaging to assess neurotransmitter release in brain
Finnema, S. J., Scheinin, M., Shahid, M., Lehto, J., Borroni, E., Bang-Andersen, B., Sallinen, J., Wong, E., Farde, L., Halldin, C., et al. (2015) · Psychopharmacology · doi:10.1007/s00213-015-3938-6 · Cited by 78
“Dopaminewas also the first neurotransmitter for which changes in extracellular concentrations could be evaluated in the living human brain using PET and SPECT (Farde et al. 1992; Laruelle et al. 1995; Volkow et al. 1994).”
BackgroundVolkow, N. D., Ding, Y., Fowler, J. S., & Gatley, S. J. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(00)01112-4 · Cited by 87
“Both are sensitive to changes in endogenous concentration of the neurotransmitter (Dewey et al 1993; Laruelle et al 1997; Volkow et al 1994).”
Self-citationAbosch, A., Kapur, S., Lang, A. E., Hussey, D. F., Sime, E., Miyasaki, J. M., Houle, S., & Lozano, A. M. (2003) · Neurosurgery · doi:10.1227/01.neu.0000088662.69419.1b · Cited by 86
“There are now numerous human studies demonstrating significant changes in [(11)C]raclopride binding as a consequence of interventions that cause acute changes in synaptic dopamine release (4, 7, 12, 30, 31).”
BackgroundEndres, C. J., & Carson, R. E. (1998) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199811000-00006 · Cited by 82
Hietala, J., Någren, K., Lehikoinen, P., Ruotsalainen, U., & Syvälahti, J. (1999) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199902000-00012 · Cited by 79
Dyskinesias and dopamine cell replacement in Parkinson's disease: a clinical perspective
Hagell, P., & Cenci, M. A. (2004) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2004.10.013 · Cited by 85
Booij, J., Korn, P., Linszen, D. H., & van Royen, E. A. (1997) · European Journal of Nuclear Medicine · doi:10.1007/bf00841408 · Cited by 77
“Interestingly, other studies have reported a comparable increase in restlessness after injection of amphetamine-like drugs [4, 5].”
BackgroundMethodInfluentialGinovart, N., Farde, L., Halldin, C., & Swahn, C.-G. (1999) · Synapse · doi:10.1002/(sici)1098-2396(199902)31:2<154::aid-syn9>3.0.co;2-k · Cited by 77
Serotonergic modulation of dopamine measured with [11C]raclopride and PET in normal human subjects
(1997) · American Journal of Psychiatry · doi:10.1176/ajp.154.4.490 · Cited by 75
“931-08/12 tomograph as described previously (7).”
Self-citationGinovart, N. (2004) · Molecular Imaging and Biology · doi:10.1007/s11307-005-0932-0 · Cited by 85
Ginovart, N., Wilson, A. A., Meyer, J. H., Hussey, D., & Houle, S. (2003) · Synapse · doi:10.1002/syn.10155 · Cited by 72
“Indeed, the binding [11C]raclopride in the striatum of nonhuman primates is decreased by drugs that elevate synaptic dopamine and is increased by drugs that decrease synaptic dopa- mine (Hume et al., 1992; Dewey et al., 1993; Volkow et al., 1994; Ginovart et al., 1997).”
BackgroundIs increased D2 receptor availability associated with response to stimulant medication in ADHD
Ilgin, N., Senol, S., Gucuyener, K., Gokcora, N., Atavci, S., & Sener, S. (2001) · Developmental Medicine and Child Neurology · doi:10.1017/s0012162201001384 · Cited by 73
Elliott, L., Ream, G., McGinsky, E., & Dunlap, E. (2012) · International Journal of Mental Health and Addiction · doi:10.1007/s11469-012-9391-4 · Cited by 66
“%) reduction in dopamine d2 receptor binding potential in the caudate after play (Weinstein 2010), suggesting a video game related dopamine release comparable to that produced by amphetamine or methylphenidate (e.g., Volkow et al. 1994).”
Abi‐Dargham, A., Kegeles, L. S., Martínez, D., Innis, R. B., & Laruelle, M. A. (2003) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2003.08.007 · Cited by 84
Verhoeff, N. P. L. G., Kapur, S., Hussey, D., Lee, M., Christensen, B. K., Psych, C., Papatheodorou, G. N., & Zipursky, R. B. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00231-7 · Cited by 83
Savitz, J., Hodgkinson, C. A., Martin-Soelch, C., Shen, P.-H., Szczepanik, J., Nugent, A., Herscovitch, P., Grace, A. A., Goldman, D., & Drevets, W. C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0054108 · Cited by 69
“Since DA is released in the NAc in response to unpredicted reward [33], the degree of displacement of [(11)C]raclopride by the increase in intrasynaptic DA concentrations during reward would then be evident by changes in the radioligand binding to either D2 or D3 receptors [34,35].”
BackgroundMarquand, A. F., O'Daly, O. G., De Simoni, S., Alsop, D. C., Maguire, R. P., Williams, S. C. R., Zelaya, F. O., & Mehta, M. A. (2012) · NeuroImage · doi:10.1016/j.neuroimage.2012.01.058 · Cited by 72
“…in the caudate body, congruent with multiple lines of evidence showing that MPH increases striatal DA concentrations (e.g. Bymaster et al., 2002; Volkow et al., 1994), although the striatum was not observed following methylphenidate challenge in human H2[O15] PET studies (Mehta et al., 2000;…”
BackgroundStriatal dopaminergic dysfunction at rest and during task performance in writer’s cramp
Berman, B. D., Hallett, M., Herscovitch, P., & Simonyan, K. (2013) · Brain · doi:10.1093/brain/awt282 · Cited by 72
“(Seeman et al., 1989; Volkow et al., 1994; Beaulieu and Gainetdinov, 2011).”
BackgroundVolkow, N. D., Tomasi, D., Wang, G.-J., Telang, F., Fowler, J. S., Wang, R. L., Logan, J., Wong, C., Jayne, M., & Swanson, J. M. (2009) · NeuroImage · doi:10.1016/j.neuroimage.2009.01.003 · Cited by 68
“Dynamic scans were started immediately after iv injection of 4–10 mCi of [ 11 C] raclopride (specific activity>0.25 Ci/µmol at time of injection) for a total of 60min as previously described (Volkow et al., 1994).”
InfluentialSelf-citationOuchi, Y., Yoshikawa, E., Futatsubashi, M., Okada, H., Torizuka, T., & Sakamoto, M. (2002) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-200206000-00013 · Cited by 67
“also allows us to study the dynamic aspect of pathophysiology in PD by taking advantage of D2 and -3 receptors ligand [(11)C]raclopride ([(11)C]RAC), the binding of which reportedly varies depending on synaptic endogenous dopamine level in vivo (Hume et al., 1992; Volkow et al., 1994).”
BackgroundA PET study of D 1 -like dopamine receptor ligand binding
Chou, Y.-H., Karlsson, P., Halldin, C., Olsson, H., & Farde, L. (1999) · Psychopharmacology · doi:10.1007/s002130051110 · Cited by 73
Slifstein, M., Narendran, R., Hwang, D., Sudo, Y., Talbot, P. S., Huang, Y., & Laruelle, M. (2004) · Synapse · doi:10.1002/syn.20062 · Cited by 69
“If rCBF does vary during the scan, artifactual changes in measured distribution volumes may result, leading to inaccurate inferences regarding the effect of amphetamine on specific binding (Volkow et al., 1994; Laruelle, 2000).”
BackgroundMethodImaging of Cholinergic and Monoaminergic Neurochemical Changes in Neurodegenerative Disorders
Bohnen, N. I., & Frey, K. A. (2007) · Molecular Imaging and Biology · doi:10.1007/s11307-007-0083-6 · Cited by 70
Methylphenidate and substance abuse: A review of pharmacology, animal, and clinical studies
Huss, M., & Lehmkuhl, U. (2002) · Journal of Attention Disorders · doi:10.1177/070674370200601s09 · Cited by 66
Kim, J. Y., Chung, E. J., Lee, W. Y., Shin, H. Y., Lee, G. H., Choe, Y. S., Choi, Y. S., & Kim, B. J. (2007) · Movement Disorders · doi:10.1002/mds.21787 · Cited by 62
Finnema, S. J., Varrone, A., Hwang, T. J., Gulyás, B., Pierson, M. E., Halldin, C., & Farde, L. (2010) · Synapse · doi:10.1002/syn.20780 · Cited by 62
Central Insulin Modulates Dopamine Signaling in the Human Striatum
Kullmann, S., Blum, D., Jaghutriz, B. A., Gassenmaier, C., Bender, B., Häring, H., Reischl, G., Preissl, H. T., la Fougère, C., Fritsche, A., et al. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab410 · Cited by 62
Systemic inflammation enhances stimulant-induced striatal dopamine elevation
Petrulli, J. R., Kalish, B., Nabulsi, N., Huang, Y. H., Hannestad, J. O., & Morris, E. D. (2017) · Translational Psychiatry · doi:10.1038/tp.2017.18 · Cited by 63
Morris, E. D., Chefer, S. I., Lane, M. A., Muzic, R. F., Wong, D. F., Dannals, R. F., Matochik, J. A., Bonab, A. A., Villemagne, V. L., Grant, S. J., et al. (1999) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199902000-00013 · Cited by 60
Imaging extrastriatal dopamine D2 receptor occupancy by endogenous dopamine in healthy humans
Fujita, M., Verhoeff, N. P. L. G., Varrone, A., Zoghbi, S. S., Baldwin, R. M., Jatlow, P. A., Anderson, G., Seibyl, J. P., & Innis, R. B. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00817-1 · Cited by 67
Scott, D. J., Stohler, C. S., Koeppe, R. A., & Zubieta, J. (2007) · Synapse · doi:10.1002/syn.20404 · Cited by 57
“Similar observations were obtained with other DA-releasing agents (e.g., methylphenidate) and with a variety of radiopharmaceuticals targeting DA D2 receptors (Dewey et al., 1991; Endres et al., 1997; Laruelle et al., 1995; Narendran et al., 2004; Riccardi et al., 2006a, 2006b; Volkow et al., 1994).”
ResultThe Dopamine Hypothesis of Schizophrenia
Gründer, G., & Cumming, P. D. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-801829-3.00015-x · Cited by 70
de la Fuente‐Fernández, R., Lim, A. S. P., Sossi, V., Holden, J. E., Calne, D. B., Ruth, T. J., & Stoessl, A. J. (2001) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-200110000-00003 · Cited by 59
GABA-containing neurons in the rat ventral tegmental area project to the prefrontal cortex
Carr, D. B., & Sesack, S. R. (2000) · Synapse · doi:10.1002/1098-2396(200011)38:2<114::aid-syn2>3.0.co;2-r · Cited by 352
Volkow, N. D., Wang, G., Gatley, S. J., Fowler, J. S., Ding, Y., Logan, J., Volkow, N. D., Hitzemann, R., ANGRIST, B. M., & Lieberman, J. A. (1996) · Psychopharmacology · doi:10.1007/bf02246277 · Cited by 57
Self-citationIndividual variation in D2 dopamine receptor occupancy in clozapine- treated patients
(1996) · American Journal of Psychiatry · doi:10.1176/ajp.153.12.1571 · Cited by 59
BMI Modulates Calorie-Dependent Dopamine Changes in Accumbens from Glucose Intake
Wang, G.-J., Tomasi, D., Convit, A., Logan, J., Wong, C. T., Shumay, E., Fowler, J. S., & Volkow, N. D. (2014) · PLoS ONE · doi:10.1371/journal.pone.0101585 · Cited by 53
“For this purpose we used positron emission tomography (PET) and [(11)C]raclopride (D2/D3 receptor radiotracer sensitive to competition with endogenous DA) [13] to assess if calorie induced DA increases in ventral striatum”
MethodSelf-citationYau, Y. H. C., Gottlieb, C. D., Krasna, L. C., & Potenza, M. N. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-407724-9.00007-0 · Cited by 56
Chronic subthalamic nucleus stimulation and striatal D2 dopamine receptors in Parkinson?s disease
Thobois, S., Fraix, V., Savasta, M., Costes, N., Pollak, P., Mertens, P., Koudsié, A., Bars, D. L., Benabid, A., & Broussolle, E. (2003) · Journal of Neurology · doi:10.1007/s00415-003-0188-z · Cited by 58
“The aim of this study was to address this question by investigating the effect of HFSSTN in PD patients using Positron Emission Tomography (PET) and [11C]-Raclopride, a dopaminergic postsynaptic D2 receptor ligand, whose relatively low affinity for the D2 receptors makes it sensitive to competition with endogenous DA…”
MethodUchida, H., Suzuki, T., Mamo, D. C., Mulsant, B. H., Tanabe, A., Inagaki, A., Watanabe, K., Yagi, G., & Tomita, M. (2008) · American Journal of Geriatric Psychiatry · doi:10.1097/jgp.0b013e318172b42d · Cited by 64
“Though a significant difference in prescribed dose was not found among age groups in those inpatients (F[5, 36] 0.”
BackgroundFunctional imaging studies on dopamine and motor control
Brooks, D. J. (2001) · Journal of Neural Transmission · doi:10.1007/s007020100005 · Cited by 51
“The striatal uptake of the reversible competitive dopamine D2 antagonist 11 Craclopride is influenced by levels of synaptic dopamine ( Volkow et al., 1994 ).”
BackgroundInfluentialImaging Neurotransmitter Release by Drugs of Abuse
Martínez, D., & Narendran, R. (2009) · Current topics in behavioral neurosciences · doi:10.1007/7854_2009_34 · Cited by 53
“In human studies, the challenges used have included methylphenidate (IV and PO) (Volkow et al. 1994, 2001a, b), amphetamine (Drevets et al. 1999; Martinez et al. 2003), and cocaine (IV and intranasal) (Schlaepfer et al. 1997; Cox et al. 2009).”
Pike, V. W., Halldin, C., Wikström, H., Marchais, S., McCarron, J. A., Sandell, J., Nowicki, B., Swahn, C.-G., Osman, S., Hume, S. P., et al. (2000) · Nuclear Medicine and Biology · doi:10.1016/s0969-8051(00)00110-4 · Cited by 49
Sensitivity to Antipsychotic Drugs in Older Adults
Leon, C., Gerretsen, P., Uchida, H., Suzuki, T., Rajji, T. K., & Mamo, D. C. (2010) · Current Psychiatry Reports · doi:10.1007/s11920-009-0080-3 · Cited by 53
“Second, as endogenous dopamine levels decrease with age [44], this may contribute to dopaminergic system downregulation.”
BackgroundNimura, T., Yamaguchi, K., Ando, T., Shibuya, S., Oikawa, T., Nakagawa, A., Shirane, R., Itoh, M., & Tominaga, T. (2005) · Journal of neurosurgery · doi:10.3171/jns.2005.103.6.0968 · Cited by 49
Mach, R. H., Nader, M. A., Ehrenkaufer, R. L., Line, S. W., Smith, C. R., Gage, H. D., & Morton, T. E. (1997) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(96)00449-2 · Cited by 48
de Haes, J. I. U., Bosker, F. J., van Waarde, A., Pruim, J., Willemsen, A. T. M., Vaalburg, W., & den Boer, J. A. (2002) · Synapse · doi:10.1002/syn.10134 · Cited by 50
Houston, G. C., Hume, S. P., Hirani, E., Goggi, J. L., & Grasby, P. M. (2004) · Synapse · doi:10.1002/syn.10296 · Cited by 48
“For example, decreases in radioligand binding have been consistently recorded following stimulation by amphetamine (Volkow et al., 1994; Abi-Dargham et al., 1998), cocaine (Schlaepfer et al., 1997; Volkow et al., 1999a,b), and methylphenidate (Volkow et al., 1997, 1999a,b) and increased binding has…”
BackgroundInfluential4 Radioligands for the Study of Brain 5-HT1A Receptors In Vivo
Pike, V. W., Halldin, C., & Wikström, H. (2001) · Progress in medicinal chemistry · doi:10.1016/s0079-6468(08)70094-8 · Cited by 47
de Haes, J. I. U., Harada, N., Elsinga, P. H., Maguire, R. P., & Tsukada, H. (2005) · Synapse · doi:10.1002/syn.20209 · Cited by 47
“The extent of dopamine release, and as a result the change in ligand binding, is reported to be dependent on the level of anxiety and mood at baseline, probably reflecting baseline dopaminergic tone (Volkow et al. 1994).”
BackgroundStriatal Dopamine Release and Family History of Alcoholism
Munro, C. A., McCaul, M. E., Oswald, L. M., Wong, D. F., Zhou, Y., Brasic, J., Kuwabara, H., Kumar, A., Alexander, M., Ye, W., et al. (2006) · Alcoholism: Clinical and Experimental Research · doi:10.1111/j.1530-0277.2006.00130.x · Cited by 46
“…with the use of opioid receptor antagonists (naloxone and naltrexone), alcohol, and psychological stressors rather than amphetamine (Gianoulakis et al., 1989; Hernandez-Avila et al., 2002; King et al., 2002; Schuckit et al., 1987; Uhart et al., 2004; Waltman et al., 1994; Zimmermann et al., 2004).”
Therapeutic window of dopamine D2/3 receptor occupancy to treat psychosis in Alzheimer’s disease
Reeves, S., McLachlan, E., Bertrand, J., D’Antonio, F., Brownings, S., Nair, A., Greaves, S., Smith, A., Taylor, D. M., Dunn, J., et al. (2017) · Brain · doi:10.1093/brain/aww359 · Cited by 46
“Reduced competition with amisulpride at D2/3 receptor sites, due to age-related reductions in endogenous dopamine release (Volkow et al., 1994), also needs to be considered, although the magnitude of such changes would not be sufficient to account for the extent of the differences observed between…”
BackgroundSmith, G. S., Ma, Y., Dhawan, V., Gunduz, H., Carbon, M., Kirshner, M., Larson, J., Chaly, T., Belakhleff, A., Kramer, E., et al. (2002) · Synapse · doi:10.1002/syn.10088 · Cited by 46
“…function would be to measure changes in serotonin receptor availability secondary to pharmacologic induced changes in endogenous serotonin concentrations using a paradigm similar to that developed for the dopamine system using [11C]-raclopride (e.g., Dewey et al., 1993; Volkow et al., 1994).”
Oswald, L. M., Wand, G. S., Wong, D. F., Brown, C. H., Kuwabara, H., & Brašić, J. R. (2015) · NeuroImage · doi:10.1016/j.neuroimage.2015.03.022 · Cited by 45
“Our group (Oswald et al., 2014) and others (Volkow et al., 1994) have previously observed associations between baseline anxiety and stimulant-induced DA release.”
BackgroundSmith, G. S., Gunning‐Dixon, F. M., Lotrich, F. E., Taylor, W. D., & Evans, J. D. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301333 · Cited by 48
“…function and interactions between monoamine systems The early focus of this work was on the measurement of striatal dopamine concentrations (eg, Dewey et al, 1993; Volkow et al, 1994) and modulation by other neurotransmitter systems (eg, serotonin, glutamate; as reviewed by Smith et al, 2004).”
BackgroundIn Vivo Imaging of Neurotransmitter Systems Using Radiolabeled Receptor Ligands
Kegeles, L. S., & Mann, J. J. (1997) · Neuropsychopharmacology · doi:10.1016/s0893-133x(97)00069-9 · Cited by 48
Prasad, K., de Vries, E. F. J., Elsinga, P. H., Dierckx, R., & van Waarde, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22041719 · Cited by 44
Laruelle, M. A. (2012) · Neuromethods · doi:10.1007/7657_2012_45 · Cited by 47
Volkow, N. D., Tomasi, D. G., Wang, G., Telang, F., Fowler, J. S., Logan, J., Maynard, L. J., & Wong, C. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.5261-12.2013 · Cited by 45
“…are not occupied by endogenous DA) was used to measure MP-induced changes in DA by comparing radiotracer binding between placebo and MP conditions (Volkow et al., 1994), while [ 18F]deoxyglucose (FDG) was used to measure the effects of MP (compared with placebo) on brain glucose metabolism…”
MethodSelf-citationRadiotracers for positron emission tomography imaging
Fowler, J. S., Ding, Y., & Volkow, N. D. (2003) · Seminars in Nuclear Medicine · doi:10.1053/snuc.2003.127297 · Cited by 44
Self-citationWiers, C. E., Shokri-Kojori, E., Cabrera, E., Cunningham, S., Wong, C., Tomasi, D., Wang, G.-J., & Volkow, N. D. (2016) · Neuroscience Letters · doi:10.1016/j.neulet.2016.01.056 · Cited by 41
Self-citationApplying Neuroimaging Ligands to Study Major Depressive Disorder
Meyer, J. H. (2008) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2008.02.007 · Cited by 43
Reduced sleep duration mediates decreases in striatal D2/D3 receptor availability in cocaine abusers
Wiers, C. E., Shumay, E., Cabrera, E., Kojori, E. S., Gladwin, T. E., Skarda, E., Cunningham, S. I., Kim, S. W., Wong, T. C., Tomasi, D. G., et al. (2016) · Translational Psychiatry · doi:10.1038/tp.2016.14 · Cited by 43
Self-citationGinovart, N., Wilson, A. A., Houle, S., & Kapur, S. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.02.019 · Cited by 49
Finnema, S. J., Varrone, A., Hwang, T.-J., Halldin, C., & Farde, L. (2012) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2011.172 · Cited by 40
“Confirmation of fenfluramine effect on 5-HT1B receptor binding of [11C]AZ10419369 using an equilibrium approach Sjoerd J Finnema1, Andrea Varrone1, Tzung-Jeng Hwang1,3, Christer Halldin1,4 and Lars Farde1,2,4 1Psychiatry Section, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden; 2AstraZene…”
BackgroundSleep deprivation differentially affects dopamine receptor subtypes in mouse striatum
Lim, M. M., Xu, J., Holtzman, D. M., & Mach, R. H. (2011) · Neuroreport · doi:10.1097/wnr.0b013e32834846a0 · Cited by 42
Metadata
- Authors
- Volkow, N. D., Wang, G., Fowler, J. S., Logan, J., Schlyer, D., Hitzemann, R., Lieberman, J., Angrist, B., Pappas, N., MacGregor, R., Burr, G., Cooper, T., & Wolf, A. P.
- Affiliations
- State University of New York (US)
- Brookhaven National Laboratory (US)
- Zucker Hillside Hospital (US)
- New York University (US)
- Northport VA Medical Center (US)
- Venue
- Synapse
- Publisher
- Wiley
- Published
- 1994-04
- Volume
- 16
- Issue
- 4
- Pages
- 255-262
- ISSN
- 0887-4476 (ISSN-L)
- 1098-2396
- OpenAlex
- W2006715508
- Cited by
- 379
- References
- 68
- Citations by year
- 2026: 4 · 2025: 6 · 2024: 3 · 2023: 5 · 2022: 7 · 2021: 10 · 2020: 5 · 2019: 8 · 2018: 2 · 2017: 9 · 2016: 6 · 2015: 13 · 2014: 16 · 2013: 12 · 2012: 12
- FWCI
- 4.66
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Synapse (publishedVersion)
- PubMed (publishedVersion)
- Funders
- U.S. Department of Energy
- National Institutes of Health (5p01ns015638-15)
- National Institute on Drug Abuse (NIDA 5RO1-DA06891, R01DA006891)
- National Institute of Neurological Disorders and Stroke (NINDS NS15638)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Medical Imaging Techniques and Applications
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Keywords
- endogenous dopamine, dopamine release, [11C]raclopride, dopamine D2 receptor, striatal dopamine, psychostimulants, age-related changes, mood, anxiety
- MeSH terms
- Adult, Affect, Anxiety, Basal Ganglia, Binding, Competitive, Brain, Brain Chemistry, Cerebrovascular Circulation, Dopamine, Humans, Male, Methylphenidate, Middle Aged, Salicylamides, Synapses, Tomography, Emission-Computed, Neostriatum, Raclopride, Dopamine D2 Receptor Antagonists
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.